Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2003
05/29/2003US20030099621 Screening cells to identify stem cells having a beneficial gene, and transplanting the cells into a patient to treat HIV or AIDS
05/29/2003US20030099620 Bonding two cartilage pieces with an adhesive material isolated chondrocytes in gels; implants for repairing bone defects
05/29/2003US20030099619 Method and composition for targeting an adenoviral vector
05/29/2003US20030099618 Administering a genetic engineered virus virions, comprising a nucleotide sequence able to code antihemophilic factor protein; patient's blood will able to clot
05/29/2003US20030099615 Porcine adenovirus E1 and E4 regions
05/29/2003US20030099614 2-Methoxyestradiol-induced apoptosis in cancer cells
05/29/2003US20030099613 An encoded repressor or activator and a viral nucleotide sequence for replication; preparing a vaccine for the prophylaxis of AIDS, human immunodeficiency virus
05/29/2003US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
05/29/2003US20030099609 Canine IL-4 nucleic acid molecules and uses thereof
05/29/2003US20030099608 Human cytokine receptor
05/29/2003US20030099607 Ifn-y production inducing protein (igif, il-18)
05/29/2003US20030099580 Universal microscope slide cassette
05/29/2003US20030097824 Specimen vial sealing apparatus and method
05/28/2003EP1314784A1 G-protein coupled receptor LUSTR2 and uses thereof
05/28/2003EP1314741A1 Bispecific anti-CD19 x anti-CD16 antibodies and uses thereof
05/28/2003EP1314440A2 Cultured skin and method of maufacturing the same
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
05/28/2003EP1313885A2 Methods of using agents that modulate bone formation and inhibit adipogenesis
05/28/2003EP1313883A2 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
05/28/2003EP1313882A2 Diagnosis and treatment of prostate cancer
05/28/2003EP1313870A2 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above
05/28/2003EP1313869A2 Helper functions for recombinant vector production
05/28/2003EP1313868A2 Transgenic plants containing molecular decoys that alter protein content therein
05/28/2003EP1313863A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins
05/28/2003EP1313860A2 Butinol i esterase
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313855A2 Truncated bard1 protein, and its diagnostic and therapeutic uses
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313851A2 Methods and reagents for molecular cloning
05/28/2003EP1313844A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof
05/28/2003EP1313839A1 Immune potentiating compositions
05/28/2003EP1313768A2 Antisense oligonucleotides against vr1
05/28/2003EP1313762A2 Suppressor gene
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP1313360A1 An improved process for cultivation of algae
05/28/2003EP1163018B1 Mineralization and cellular patterning on biomaterial surfaces
05/28/2003EP1143983A4 Spray delivery of cells
05/28/2003EP1135500A4 Control of flowering
05/28/2003EP1037966B1 Industrial production of meat from in vitro cell cultures
05/28/2003EP0988048A4 Ligand/lytic peptide compositions and methods of use
05/28/2003EP0973868A4 Evaluation of changes in breast cells using nipple aspirate fluid
05/28/2003EP0938332A4 Use of delta-like protein to inhibit the differentiation of stem cells
05/28/2003EP0909314A4 Plant sugar sensors and uses thereof
05/28/2003EP0871457B1 Isolated stromal cells and methods of using the same
05/28/2003EP0651783B1 Alkaline phosphatase enzyme having improved specific activity for use in indicator reagents
05/28/2003CN2552934Y Pressure circulating ultra-high pressure cell rupture device
05/28/2003CN1420936A Identification of cells for transplantation
05/28/2003CN1420933A Method of inducing angiogenesis by micro-organs
05/28/2003CN1420932A Apomixis conferred by expression of SERK interacting proteins
05/28/2003CN1420925A Method for modulating nitrilase selectivety, nitrilases obtained by said method and use thereof
05/28/2003CN1420923A Infection of eukaryotic cells with viruses in vitro
05/28/2003CN1420893A Method and compositions for generating human monoclonal antibodies
05/28/2003CN1420789A Compound for targeting
05/28/2003CN1420785A Method of treating cancer with anti-neurotrophin agents
05/28/2003CN1420721A Formulation of preservation mixtures conty. sensitive biologicals to be stabilized for ambient temp. storage by drying
05/28/2003CN1420168A Electrophoresis selection of forest tree disease-resistant cell line
05/28/2003CN1109759C Biochemical analysis of antioxidant function
05/28/2003CN1109753C Imidazolinone herbicide resistant sugar beet plants
05/28/2003CN1109749C Pressure-mediated intracellular delivery of molecules or microparticles
05/27/2003US6570065 Nucleotide sequences coding enzymatic polypeptide for use in textile, foods and cosmetics
05/27/2003US6570061 Generating transgenic animal; obtain animal blastocyst, transform with expression vector coding immunoglobulin, propagate blastocyst and recover trangenic animal
05/27/2003US6570040 Chemoselective ligation
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6570001 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569996 Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
05/27/2003US6569994 Human blue-light photoreceptor hCRY2
05/27/2003US6569992 Protein for use in the treatment of immunological, liver, reproductive and infectious disorders
05/27/2003US6569831 Recombinant lactoferrin, methods of production from plants and uses
05/27/2003US6569681 Methods of improving homologous recombination
05/27/2003US6569680 Efficient method of protoplast culture
05/27/2003US6569677 Viral genome mutations involving the recognition and binding of natural cell receptors for adenoviruses; use in human gene therapy applications
05/27/2003US6569666 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
05/27/2003US6569658 Proteins and nucleic acids which have an effect on or are related to cell cycle regulation; use in assays screening for cell cycle modulators and as therapeutics
05/27/2003US6569656 Synthases
05/27/2003US6569655 For use in therapeutics, diagnostics, and as research tools
05/27/2003US6569654 Electroactive materials for stimulation of biological activity of stem cells
05/27/2003US6569645 IL-17 homologous polypeptides and therapeutic uses thereof
05/27/2003US6569643 Expression vector for use as tool in genetic engineering
05/27/2003US6569642 TNF-Related Apoptosis-Inducing Ligand (TRAIL); isolated DNA probe which hybridizes to nucleic acid of given sequence; use in purifying cells, inhibiting biological activities or as immunogens to produce antibodies
05/27/2003US6569464 Antifertility agent comprises coelomic fluid extract which is obtained from an Indian earthworm, Pheretima posthuma, belonging to the phylum, Annelida
05/27/2003US6569442 Preparation of polymer foam having gelled sol coating for intervertebral disc reformation
05/27/2003US6569429 Isolated polypeptide comprising the amino acid residues 1 to 344 of (SEQ ID NO: 2); systemic lupus erythematosus; pulmonary disease or disorder
05/27/2003US6569428 For regulating angiogenesis; nucleic acid encoding an endothelial cell mitogen and endothelial cell progenitors, where the EC progenitors are CD34+, Flk-1+, and tie-2+
05/27/2003US6569427 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
05/27/2003US6569422 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants
05/27/2003US6569421 Administering pluripotent cells into the damaged brain, wherein administration is into the brain hemisphere contra-lateral to that containing the site of damage
05/27/2003US6569420 Human interferon-ε: a type I interferon
05/27/2003CA2273855C Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
05/27/2003CA2179208C Human cns receptor polynucleotides
05/27/2003CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments
05/23/2003WO2002042475A1 Gene hd3a inducing flowering of plant and utilization thereof
05/22/2003WO2003042723A2 Optical cell guidance method and apparatus
05/22/2003WO2003042693A2 Method for measuring intracellular atp and/or gene expression
05/22/2003WO2003042405A2 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/22/2003WO2003042401A2 Novel chromophores/fluorophores and methods for using the same